25TFM-NBOMe

25TFM-NBOMe is a psychedelic and hallucinogenic drug that is part of the 2C family. It is known for its potent serotonin receptor agonist properties. This drug is not commonly used and little is known about its effects and metabolism.

History

25TFM-NBOMe was first synthesized by a team at Purdue University. It was later studied by David E. Nichols as a potential serotonin receptor agonist.

Pharmacology

25TFM-NBOMe is a potent partial agonist for the 5-HT2A receptor. The exact effects of this on the human body are not well understood due to the lack of research and reports in this area.

Effects

The effects of 25TFM-NBOMe are not well documented. As a psychedelic, it is assumed to produce effects similar to other drugs in the 2C family, such as 2C-B and 2C-I. These effects can include hallucinations, changes in perception, euphoria, and anxiety. However, the exact effects can vary greatly depending on the individual and dose.

Legal Status

The legal status of 25TFM-NBOMe varies by country. In the United States, it is not specifically listed as a controlled substance, but it may be considered illegal under the Federal Analogue Act if intended for human consumption.

See Also

• 2C
• Psychedelic drug
• Hallucinogen
• David E. Nichols
• 5-HT2A receptor

References

25TFM-NBOMe Resources
Latest articles Most recent articles Ongoing trials	Wikipedia